1423 POSTER Polymorphism Analysis in the AVADO Randomised Phase III Trial of First-line Bevacizumab (BEV) Combined With Docetaxel in HER2-negative Metastatic Breast Cancer (mBC)
2011 ◽
Vol 47
◽
pp. S176
◽
Keyword(s):
2006 ◽
Vol 94
(9)
◽
pp. 1233-1236
◽
Keyword(s):
Keyword(s):
2011 ◽
Keyword(s):
2004 ◽
Vol 22
(14_suppl)
◽
pp. 515-515
◽
Keyword(s):
Keyword(s):
Keyword(s):
2004 ◽
Vol 22
(14_suppl)
◽
pp. 627-627
◽
Keyword(s):
2004 ◽
Vol 22
(14_suppl)
◽
pp. 515-515
◽
Keyword(s):
2013 ◽
Keyword(s):
Keyword(s):